BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments ...

The announcement of new investment was first made by CEO Christopher Boerner in an opinion piece published in Stat News on ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...

Bristol Myers Squibb will spend $40 billion in the US over the next five years, CEO Christopher Boerner wrote in an opinion ...

US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.

Bristol Myers Squibb has appointment Cari Gallman as executive vice president, general counsel and chief policy officer, ...

Gallman takes on the role of EVP, General Counsel and Chief Policy Officer, following Sandra Leung’s retirement after 33 ...

A new executive order aims to smooth the path for getting U.S. manufacturing facilities up and running; HHS says it will ...

Bristol Myers Squibb (BMS) plans to invest $40bn in the US over the next five years to bolster its research and manufacturing ...

BMS CEO Christopher Boerner first revealed the plans in an opinion piece published in Stat News, in which he stated that the funds will be allocated for research and development (R&D), on ...

Princeton: Bristol Myers Squibb has announced the appointment of Cari Gallman as Executive Vice President, General Counsel ...